CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Nitrosative stress drives heart failure with preserved ejection fraction Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead? Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure HFpEF: From Mechanisms to Therapies Heart Failure With Preserved Ejection Fraction in the Young Functional Impairment and Medication Burden in Adults With Heart Failure

Original Research2021 Mar 2.

JOURNAL:Eur J Heart Fail. Article Link

Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction

RJ Woolley, D Ceelen, W Ouwerkerk et al. Keywords: HFpEF; biomarker; subgroup profile; cluster analysis

Full Text PDF